-
Published 5/20/2026
Wijk M, Denti P, Gausi K, Myers B, Carney T, White LF, Theron D, Parry CDH, Horsburgh CR, Rawoot N, Warren RM, Court R, Kulkarni SG, Farhat MR, Buys C, Malatesta S, Weber SE, Kulkarni S, McIlleron H, Jacobson KR, Kloprogge F. Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment. Clin Infect Dis. 2026 May 20; 82(5):e1014-e1022. PMID: 41133922.
-
Published 5/15/2026
Campbell JI, Vachharajani O, Dubois MM, Martinez L, Christos PJ, Herlihy JM, Jenkins HE, Horsburgh CR, Jacobson KR, Powis KM. Tuberculosis in children who are HIV-exposed uninfected: A systematic review and metaanalysis. AIDS. 2026 May 15. PMID: 42138367.
-
Published 5/14/2026
Brown TS, Nelson K, Kissler S, Martinez L, Horsburgh CR, White LF, Mathema B, Jacobson KR. Understanding and exploiting superspreading to disrupt Mycobacterium tuberculosis transmission. Lancet Infect Dis. 2026 May 14. PMID: 42134384.
-
Published 5/4/2026
Gallini J, Singh UB, Dauphinais M, Sarkar S, Carwile M, Kumar R, Rao R, Chaudhary A, McQuaid CF, Maloomian K, Sinha S, Mehta S, Dowdy DW, Liu AF, Linas BP, Horsburgh CR, White LF, Sinha P. Cost-effectiveness of in-kind nutritional support for impoverished persons with tuberculosis to reduce mortality and disengagement from care in India: a modelling study. BMJ Glob Health. 2026 May 04; 11(5). PMID: 42082204.
-
Published 5/1/2026
Zheng A, Pletner E, Middelkoop K, Neilan AM, Horsburgh CR, Paltiel AD, Freedberg KA, Wood R, Reddy KP. Potential long-acting tuberculosis treatment for people with HIV: cost-effectiveness benchmarks. Ann Am Thorac Soc. 2026 May 01; 23(5):745-753. PMID: 41721756.